People With Diabetes Using Insulin Flying Across Multiple Time Zones : Limitations and Opportunities for Diabetes Technologies
Copyright © 2023 AACE. Published by Elsevier Inc. All rights reserved..
Increasingly, people with diabetes (PWD) are using wearable and other devices to support self-management. During air travel, there are 4 stakeholders involved in maximizing the safety of wireless devices for diabetes care used in flight: (1) manufacturers of the devices, (2) airlines, (3) the Transportation Security Administration, and (4) the U.S. Food and Drug Administration. These stakeholders have all developed technologies and policies that assist PWD who prepare for and take appropriate actions during long-haul flights. This article discusses the performance and use of 6 classes of specific wireless diabetes devices during an airplane flight, including the following: (1) blood glucose monitors, (2) continuous glucose monitors, (3) insulin pumps, (4) smart pens for dosing insulin injections, (5) advanced hybrid closed-loop systems, and (6) spinal cord stimulators for painful diabetic neuropathy. Through the policies and safeguards of the 4 stakeholders and the proper self-care measures that insulin-using PWD can take, it is possible to maintain safe glycemic levels on flights across multiple time zones.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:29 |
|---|---|
| Enthalten in: |
Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists - 29(2023), 10 vom: 24. Okt., Seite 830-847 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Huang, Jingtong [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Diabetes |
|---|
| Anmerkungen: |
Date Revised 06.10.2023 published: Print-Electronic Citation Status Publisher |
|---|
| doi: |
10.1016/j.eprac.2023.07.003 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM359606881 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM359606881 | ||
| 003 | DE-627 | ||
| 005 | 20231226081234.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.eprac.2023.07.003 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1198.xml |
| 035 | |a (DE-627)NLM359606881 | ||
| 035 | |a (NLM)37460058 | ||
| 035 | |a (PII)S1530-891X(23)00472-X | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Huang, Jingtong |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a People With Diabetes Using Insulin Flying Across Multiple Time Zones |b Limitations and Opportunities for Diabetes Technologies |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Revised 06.10.2023 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status Publisher | ||
| 520 | |a Copyright © 2023 AACE. Published by Elsevier Inc. All rights reserved. | ||
| 520 | |a Increasingly, people with diabetes (PWD) are using wearable and other devices to support self-management. During air travel, there are 4 stakeholders involved in maximizing the safety of wireless devices for diabetes care used in flight: (1) manufacturers of the devices, (2) airlines, (3) the Transportation Security Administration, and (4) the U.S. Food and Drug Administration. These stakeholders have all developed technologies and policies that assist PWD who prepare for and take appropriate actions during long-haul flights. This article discusses the performance and use of 6 classes of specific wireless diabetes devices during an airplane flight, including the following: (1) blood glucose monitors, (2) continuous glucose monitors, (3) insulin pumps, (4) smart pens for dosing insulin injections, (5) advanced hybrid closed-loop systems, and (6) spinal cord stimulators for painful diabetic neuropathy. Through the policies and safeguards of the 4 stakeholders and the proper self-care measures that insulin-using PWD can take, it is possible to maintain safe glycemic levels on flights across multiple time zones | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Review | |
| 650 | 4 | |a diabetes | |
| 650 | 4 | |a glycemic management | |
| 650 | 4 | |a long-haul flight | |
| 650 | 4 | |a medical portable electronic device | |
| 650 | 4 | |a security | |
| 650 | 4 | |a wireless connectivity | |
| 700 | 1 | |a Yeung, Andrea M |e verfasserin |4 aut | |
| 700 | 1 | |a Klonoff, David C |e verfasserin |4 aut | |
| 700 | 1 | |a Abdel-Malek, Aiman |e verfasserin |4 aut | |
| 700 | 1 | |a Ahn, David T |e verfasserin |4 aut | |
| 700 | 1 | |a Kerr, David |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists |d 1995 |g 29(2023), 10 vom: 24. Okt., Seite 830-847 |w (DE-627)NLM095479376 |x 1530-891X |7 nnns |
| 773 | 1 | 8 | |g volume:29 |g year:2023 |g number:10 |g day:24 |g month:10 |g pages:830-847 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.eprac.2023.07.003 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 29 |j 2023 |e 10 |b 24 |c 10 |h 830-847 | ||